Sulfonated immunoglobulin improves cardiopulmonary functions by promoting IGF-I production in ARDS patients with severe sepsis

It has been emphasized that severe sepsis often leads to shock and ARDS in critically ill patients. We reported previously that sulfonated immunoglobulin (sIG) administration significantly inhibited the increase of in lung MPO activities and the increase of pulmonary vascular permeability. In the present study, we examined whether sIG improves not only ARDS but also cardiovascular dysfunction in patients with severe sepsis.